Stockwinners Market Radar for June 14, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:56 EDT AT&T CFO 'comfortable' that company can deliver improved ARPU trends in FY22 - AT&T CFO Pascal Desroches spoke at the Credit Suisse Annual Communications Conference where he provided an update to shareholders, stating: "1) The company continues to grow customer relationships in its strategic focus areas of 5G and fiber. Desroches said the company continues to see healthy consumer demand even with continued expectations that 2022 postpaid wireless industry demand is unlikely to replicate 2021 levels. AT&T continues to successfully attract high-value customers with its consistent, simple go-to-market strategy. 2) Desroches remains comfortable that the company can deliver improving postpaid phone ARPU trends in 2022. He noted that postpaid phone ARPU could in fact edge up sequentially in the second quarter. 3) Desroches also reiterated expectations for gradual improvement in year-over-year mobility EBITDA trends through the course of 2022. Following a more pronounced impact in the second quarter, the revenue and EBITDA impacts of the previously announced 3G network shutdown and the absence of approximately $100 million in CAF II and FirstNet related reimbursements are expected to be more than mitigated in the back half of year by organic service revenue growth and the lapping of 3G shutdown costs comparisons in the second half of 2021. 4) AT&T's fiber build progress continues with expectations to achieve 30+ million customer locations by 2025. Desroches noted that AT&T is acquiring new customers and seeing strong penetration rates thanks to a straightforward go-to-market approach. 5) AT&T continues to work through its business wireline portfolio rationalization process and focus its efforts on core transport and connectivity solutions. Desroches noted that the company has yet to see a recovery in government sector demand trends which impacted the business during the first quarter. 6) With regard to the macroeconomic environment, Desroches said that the company considered a higher-than-typical level of inflation when setting 2022 budget. The company's recent pricing increases were a response to higher-than-expected inflation trends. Additionally, the company has opportunities to address the impacts of inflation with its ongoing cost savings initiative, which is expected to reach a run rate of $4+ billion by the end of this year. 7) Desroches stated the company feels good about its financial flexibility, does not plan to issue any debt in the near-term and remains focused on its goal of achieving a net debt-to-adjusted EBITDA ratio in the 2.5x range by the end of 2023."

18:58 EDT Rio Tinto says first ore delivered at Gudai-Darri iron mine in Pilbara - Rio Tinto has delivered first ore from the Gudai-Darri iron ore mine as the company brings online its first greenfield mine in the Pilbara, Western Australia, in more than a decade. Gudai-Darri will help underpin future production of the company's flagship Pilbara Blend product. The first autonomous AutoHaul trains loaded with ore from Gudai-Darri's process plant have travelled the new 166-kilometre rail line that connects to Rio Tinto's existing rail and port infrastructure. Production from the mine will continue to ramp up through the remainder of this year and is expected to reach full capacity during 2023.

18:47 EDT Indie Semiconductor CEO: We'll cross over the profitability barrier in 2023 - In an interview on CNBC's Mad Money, Donald McClymont said Indie is fairly well spread in the market. "We're very a much a what's for lunch company," he added The company is focused on projects that can produce money today, he noted. McClymont is "committed" to being profitable by the end of 2023. "Profitability is the number one focus for me as a CEO," he said. There is no need to go to the market for funding, he noted.

18:20 EDT Maximus director buys $1.0M in common stock - In a regulatory filing, Maximus disclosed that its director Raymond Ruddy bought 17.3K shares of common stock on June 14th in a total transaction size of $1.0M.

17:42 EDT Tupperware Brands director Harbour purchases $256.5K in company shares - Tupperware Brands director Pamela Jones Harbour purchased 45,000 shares of company at $5.70 per share on June 14, for a total transaction amount of $256,500.

17:30 EDT Future Health ESG Corp trading resumes

17:20 EDT Raytheon Technologies awarded $866.63M Missile Defense Agency contract - Raytheon was awarded a sole-source, hybrid contract for $866.63M to perform the manufacture and assembly of Standard Missile-3 Block IIA All-Up Rounds for the U.S. government and Japan Ministry of Defense, or JMOD, Foreign Military Sales, or FMS, case requirements. The work will be performed in Tucson, Arizona; and Huntsville, Alabama, with an expected completion date of Dec. 31, 2026. FY21 procurement, Defense wide funds in the amount of $250.39M and FY22 procurement, Defense wide funds in the amount of $384.13M, will be obligated at time of award. JMOD FMS funds in the amount of $195.76M are available for obligation at the time of option exercise. The Missile Defense Agency is the contracting activity.

17:16 EDT Raytheon Technologies awarded $4.39B Navy contract modification - Raytheon Technologies was awarded a not-to-exceed $4.39B undefinitized modification to a previously awarded cost-plus-incentive-fee, fixed-price incentive contract. This modification adds scope for the production and delivery of Lot 15 and 16 F-35 Lighting II Joint Strike Fighter propulsion systems to include 152 F135-PW-100 propulsion systems and 26 F135-PW-600 propulsion systems for the Marine Corps, as well as long lead-time components, parts, and materials associated with F135-PW-100 and F135-PW-600 propulsion systems for non-U.S. Department of Defense, or DOD, participants and Foreign Military Sales, or FMS, customers. Additionally, this modification provides global spares requirements to include spare engines, power modules, and other hardware. This modification also provides a Block 4 Short Take-Off Vertical Landing developmental test engine for flight test efforts. Work is expected to be completed in September 2024. The Naval Air Systems Command is the contracting activity.

17:02 EDT Iveric bio director Roberts purchases 25K in company shares - Iveric bio director Calvin Roberts disclosed in a filing that he had purchased 25,000 shares of company stock at $9.62 per share, on June 13, for a total transaction amount of $240,500.

17:00 EDT Turquoise Hill announces first drawbell firing of Hugo North mine - Turquoise Hill Resources Ltd. announced that the first drawbell of the Hugo North underground mine at Oyu Tolgoi is scheduled to be fired on 17 June 2022. This is ahead of expectations and represents continued progress in terms of caving related milestones. The company is assessing any net positive impact that this may have on timing of sustainable production of Panel 0 which is currently forecast in the first half of 2023 and will update the market as appropriate.

16:41 EDT Monster Beverage authorizes new $500M share repurchase program - Monster Beverage Corporation announced that its board has authorized a new share repurchase program for the repurchase of up to an additional $500M of the company's outstanding common stock. As of June 14, approximately $157.4M remained available for repurchase under the company's previously authorized repurchase program.

16:36 EDT Vertex Energy appoints Alvaro Ruiz as chief strategy officer - Vertex Energy announced that it has appointed Alvaro Ruiz, as chief strategy officer, or CSO, a newly created role, effective June 10. As CSO, Ruiz will lead the development and execution of the company's strategy, investor relations and corporate development, including both organic and inorganic growth initiatives. Since 2013, Ruiz has served as the company's executive VP of corporate development. During his tenure with the company, he has been responsible for identifying, developing, and executing both strategic commercial and market opportunities, including the execution of the Mobile refinery acquisition in early 2022. Prior to joining Vertex, Ruiz held numerous senior management positions across the equipment manufacturing, telecom, energy, automotive and environmental services sectors. Ruiz will continue to report directly to Benjamin Cowart, president and CEO.

16:32 EDT Fast Radius appoints Pat McCusker interim CFO, John Nanry COO - Fast Radius announced the appointment of Pat McCusker as president and interim CFO and John Nanry as COO, effective June 30, 2022. McCusker and Nanry are both co-founders of Fast Radius. McCusker previously served as interim CFO for Fast Radius from 2017 to August 2021. He most recently held the position of Chief Operating Officer. Nanry most recently held the position of Chief Manufacturing and People Officer, where he led the development of Fast Radius' manufacturing operations and aligning the company's workforce planning and business strategy.

16:28 EDT Fusion announces presentation from cold antibody sub-study of FPI-1434 - Fusion Pharmaceuticals announced the presentation of imaging data from the "cold antibody sub-study" evaluating pre-administration of cold antibody, a naked antibody without the isotope, prior to administration of the imaging agent, an antibody with the isotope, in the Phase 1 study of FPI-1434 for the treatment of solid tumors expressing IGF-1R. Data were presented at the Society of Nuclear Medicine and Molecular Imaging, or SNMMI, 2022 Annual Meeting in a presentation titled "Impact of Pre-Administration of Anti-IGF-1R Antibody FPI-1175 on the Dosimetry, Tumor Uptake, and Pharmacokinetics of the IGF-1R Targeted Theranostic Imaging Agent FPI-1547 in Patients with Solid Tumors". "Pre-administration of cold antibody has the potential to increase the therapeutic index of radiopharmaceuticals through multiple avenues, including adjusting the pharmacokinetics to increase drug circulation and drive increased binding to tumor targets, saturating natural sinks for antibodies and blocking endogenous antibody binding," said CEO John Valliant. "The positive trends observed in tumor lesion uptake when cold antibody is pre-administered validate our ongoing evaluation of additional cohorts using this dosing regimen in the Phase 1 trial of FPI-1434." The cold antibody sub-study was conducted concurrently with the dose escalation portion of the Phase 1 study of FPI-1434 for the treatment of solid tumors. The sub-study was designed to determine the safety, tolerability, and effect of administration of varying doses of FPI-1175, the naked antibody without the isotope, or "cold antibody", on the biodistribution, dosimetry and tumor uptake of [111In]-FPI-1547, the investigational imaging agent.

16:24 EDT Acme United increases cash dividend 8% to 14c per share - The board of directors of Acme United declared a cash dividend of 14c per share on its outstanding common stock. The dividend is payable on July 22 to stockholders of record on the close of business on July 1.

16:24 EDT FDA panel backs Moderna COVID-19 vaccine for children aged 12-17 - FDA advisers voted unanimously that the benefits of Moderna's COVID-19 vaccine two-dose series outweigh the risks for children aged 12-17, with 22 votes for "yes" and zero "no" votes, according to multiple reports of the ongoing advisory committee meeting.

16:19 EDT La-Z-Boy Carol Lee will join CIO effective June 20 - La-Z-Boy that Carol Y. Lee will join the company as Vice President and Chief Information Officer, effective June 20 and will report to CEO Melinda D. Whittington. In this role, Lee will serve as the chief architect of the company's enterprise-wide Information Technology strategy, including the design, development and support of IT systems and programs, cybersecurity and other risk management, network optimization, ERP deployment, and infrastructure and operations support. She will lead a team of approximately 100 individuals and will ensure the company's IT strategy and execution align with La-Z-Boy Incorporated's business objectives and support its Century Vision growth strategy.

16:18 EDT Mammoth Energy announces response from FEMA - Mammoth Energy Services announced the first appeal response from the Federal Emergency Management Agency, or FEMA, related to Project Worksheet 251, commonly referred to as the first contract between Mammoth's subsidiary Cobra Acquisitions and the Puerto Rico Electric Power Authority, or PREPA. This appeal followed the May 26, 2021, determination memorandum issued by FEMA, which denied $47M of the claimed costs under the first contract. FEMA approved the appeal in part and denied the appeal in part. FEMA found that staffing costs of $24.4M are eligible for funding and that FEMA would amend Project Worksheet 251 to obligate this additional funding. Mammoth's CEO,Arty Straehla, commented: "Despite our work having received numerous third-party validations, PREPA continues to choose to pay advisors rather than its pre-existing obligations for services performed years ago. PREPA has $40.4M in federal funding sitting in a cash account set aside for our work that could be used to pay us now, yet PREPA continues to withhold payment. Astoundingly, the Financial Oversight & Management Board for Puerto Rico continues to allow PREPA to accrue interest on FEMA-approved amounts while PREPA has funds set aside and has over $1B in cash on hand. PREPA says that they can't pay when they don't have funds and won't pay when they do have funds. This lack of accountability should serve as a red flag for any entity that is considering performing work for PREPA and is bad news for people of Puerto Rico the next time a natural disaster strikes." PREPA has 60 days from the date of receipt of the determination to submit a second appeal to the Assistant Administrator, Recovery Directorate, at FEMA headquarters or to request arbitration by the Civilian Board of Contract Appeals.

16:16 EDT Montrose Environmental says it was target of organized ransomware attack - Over this past weekend, Montrose Environmental Group determined that it was the target of an organized ransomware attack. "Based on information currently available to us, we believe the incident primarily affected computers and servers within our Enthalpy Analytical laboratory network," the company said. "The fact patterns of this attack, as well as information from law enforcement and independent cybersecurity experts, lead us to believe that this attack has been carried out by highly sophisticated bad actors. Upon discovery of the attack, we took immediate action, suspending all affected systems, notifying law enforcement and activating the company's global network of IT professionals and data recovery and continuity protocols, and engaging third-party experts to begin remediating the situation. Based on the information available to us at this time, we do not believe our backup data and cloud-based enterprise systems, including email, have been affected, and we are actively working to restore impacted systems as soon as possible. Full investigation and resolution of this incident will take time, and we expect that certain lab results within our Enthalpy business will be delayed. However, we do not currently anticipate major disruption to our other services and are in the process of notifying clients as appropriate of any delays or impacts due to the attack. In the event the investigation identifies any access or other impacts to third-party data or information, we will notify the affected third parties and appropriate regulatory bodies. Though we anticipate limited impact and rapid recovery from the attack, we are closely monitoring our networks with third party security experts, and circumstances may change as we learn more about the incident. We offer our sincere apologies to customers of our laboratories and sites that have been or may be impacted by the consequences of this sophisticated cyber-attack."

16:12 EDT XpresSpa names Haynes as interim CFO, Berry separation from company June 13 - XpresSpa Group announced the separation of service with the Company of James A. Berry, effective June 13. The Company has named Omar A. Haynes as Interim Chief Financial Officer while it conducts an executive search to fill the position permanently. Scott Milford, XpresSpa Group Chief Executive Officer, said, "On behalf of our Board and the entire team, I want to thank James and wish him the best in his future endeavors. I also want to thank Omar for stepping into this interim role to help build the momentum necessary for growth. Omar is well suited to serve as our Interim Chief Financial Officer given his strong financial background and tenure with the Company. We have launched a search for a full-time Chief Financial Officer and look forward to naming that individual once they have been identified."

16:08 EDT Western Asset Mortgage names Robert Lehman as CFO - Western Asset Mortgage "announced the appointment of Robert W. Lehman as CFO, effective tomorrow, June 15th. Lehman is a real estate and REIT specialist with more than 35 years of experience in accounting, auditing, strategic plan creation and execution, capital markets and mergers and acquisitions."

16:08 EDT Five Below approves repurchase program for up to $100M in shares - Five Below announced that its board of directors has approved a stock repurchase program for up to $100M of its common shares through June 2025. The number of common shares actually repurchased, and the timing and price of repurchases, will depend upon market conditions, Securities and Exchange Commission requirements, and other factors. Shares may be repurchased from time to time on the open market, in privately negotiated transactions, or otherwise. Purchases may be started or stopped at any time without prior notice depending on market conditions and other factors.

16:07 EDT Five Below adds Match Group CEO Bernard Kim to board - Five Below (FIVE) announced its board has been expanded to 11 directors with the addition of Bernard Kim, who has been elected as a new independent director, effective immediately. Kim is the CEO of Match Group (MTCH) and brings to the board senior leadership. Additionally, Five announced that it has amended its amended and restated articles of incorporation and amended and restated bylaws to implement the company's transition to annual elections for directors and increase the maximum allowable number of directors to fourteen. Directors will be elected for one-year terms beginning with the 2023 class of directors. Later classes will also stand for one-year terms at subsequent annual meetings as their current terms expire, and the board will be fully declassified by the 2025 annual meeting when the directors in the 2022 director class complete their elected terms. Five also announced that its board of directors has approved a stock repurchase program for up to $100M of its common shares through June 2025. The number of common shares actually repurchased, and the timing and price of repurchases, will depend upon market conditions, Securities and Exchange Commission requirements, and other factors. Shares may be repurchased from time to time on the open market, in privately negotiated transactions, or otherwise. Purchases may be started or stopped at any time without prior notice depending on market conditions and other factors.

16:02 EDT MorphoSys, HIBio enter into License Agreements for Felzartamab and MOR210 - MorphoSys AG and Human Immunology Bioscience "announced that the companies entered into an equity participation agreement and license agreements to allow HIBio to develop and commercialize MorphoSys' felzartamab, an anti-CD38 antibody, and MOR210, an anti-C5aR1 antibody. Under the terms of the agreements, HIBio will obtain exclusive rights to develop and commercialize felzartamab and MOR210 across all indications worldwide, with the exception of Greater China for felzartamab and Greater China and South Korea for MOR210. As part of the agreements, MorphoSys will receive a 15% equity stake in HIBio, along with certain equity earn-in provisions and standard investment rights. MorphoSys will also be represented as a member of HIBio's Board of Directors. On achievement of development, regulatory and commercial milestones, MorphoSys will be eligible to receive payments from HIBio of up to $1B across both programs, in addition to tiered, single- to low double-digit royalties on net sales of felzartamab and MOR210 and will be compensated for ongoing program expenses. HIBio will assume full responsibility for future development and commercialization expenses. Upon signing, MorphoSys also receives an upfront payment of $15M for MOR210."

15:41 EDT Zhong Yang Financial Group Ltd trading resumes

15:26 EDT Ackman says 75 point hike tomorrow can help restore confidence in Fed - Bill Ackman said via Twitter: "The @federalreserve has allowed inflation to get out of control. Equity and credit markets have therefore lost confidence in the Fed. Market confidence can be restored if the Fed takes aggressive action with 75 bps tomorrow and in July, and a commitment to continued aggressive FF increases and QT until it is clear that inflation has been tamed. Volcker needed 20% FF for similar levels of inflation measured comparably. Assuming a 4% terminal rate gets it done is hopium. Hopefully, 5%-6% gets it done if the Fed gets there quickly."

14:40 EDT Scilex to pay RxOmeg $2M upfront for Gloperba license agreement - As consideration for the license under the license agreement announced earlier, Sorrento Therapeutics' Scilex has agreed to pay RxOmeg Therapeutics an upfront payment of $2.0M and upon Scilex's achievement of certain net sales milestones, certain milestone payments in the aggregate amount of up to $13.0. In addition, Scilex will pay certain royalties in the mid-single digit to low-double digit percentages based on annual net sales of the licensed product.

14:05 EDT PMLS adds AditxtScore to its menu of testing services. - Premier Medical Laboratory Services, PMLS adds AditxtScore to its menu of testing services. Providing more clarity regarding a patient's individual immunity profile, AditxtScore allows patients to know their level of protection that an immune response to the virus or vaccination has provided them. Now that a large segment of the population has either undergone vaccination or experienced a symptomatic or asymptomatic infection with SARS-CoV-2, AditxtScorea provides information on immune status during the current phase of the pandemic.

14:01 EDT Meihua International Medical Tech Co Ltd trading resumes

13:51 EDT Netflix working on 'Squid Game' reality competition series - Netflix is working on a reality competition series called "Squid Game: The Challenge," which is based on the hit 2021 South Korean series "Squid Game." "With both the largest cast and lump sum cash prize in reality TV history, 456 real players will enter the game in pursuit of a life-changing reward of $4.56 million," Netflix said. "As they compete through a series of games inspired by the original show - plus surprising new additions - their strategies, alliances, and character will be put to the test while competitors are eliminated around them. The stakes are high, but in this game the worst fate is going home empty-handed." Reference Link

13:17 EDT Groupon says 'streamlining technology platform' and 'embracing automation' - Groupon announced that it is taking steps to simplify the company's technology platform and "lean more into automation." "Ultimately, Groupon believes these changes will allow it to accelerate its pace of product development and support better customer and merchant experiences... When this work is completed, these actions should significantly reduce the size of Groupon's tech platform and allow it to accelerate its pace of product development focused on building a larger and more differentiated inventory base and launching products to support better customer and merchant experiences," the company stated. Sachin Devand, CTO of Groupon, said: "We have amazing talent within our Product and Engineering organization, and I believe that we can do a better job leveraging our significant tech assets to create value for all of our stakeholders. Currently, our platform is too big and too complex, and this is prohibiting us from moving as quickly as I think we can to launch new products and features. So, I've empowered the entire tech organization to challenge our long-held thought process of creating a new service for every nuance and fundamentally rethink how we structure our platform--only building and supporting what's mission critical to drive Groupon's business forward."

13:07 EDT User reports indicate problems at YouTube, Downdetector says - Reference Link

12:46 EDT NBCUniversal CEO: New Orlando park Epic Universe to be anchored by Nintendo

12:37 EDT Ad market weaker now than 'last week, last month, last year,' says NBCU CEO - NBCUniversal CEO Jeff Shell is speaking at the Credit Suisse Communications Conference.

12:29 EDT SuperCom granted 180-day extension by Nasdaq to regain compliance - SuperCom announced that it has it received a notification letter from Nasdaq that the Company has been granted an additional 180-day compliance period, or until December 12, 2022 to regain compliance with Nasdaq's minimum bid price rule. Nasdaq's determination is based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Capital Market with the exception of the bid price requirement, and the Company's written notice of its intention to cure the deficiency during the second compliance period and if necessary, by effecting a reverse stock split. Previously, in a notification letter dated December 13, 2021, Nasdaq had notified the Company that, based on the previous 30 consecutive business days, the Company's listed security no longer met the minimum $1 bid price per share requirement. Therefore, in accordance with Nasdaq's Listing Rules, the Company was provided 180 calendar days, or until June 13, 2022, to regain compliance. If at any time before December 12, 2022, the closing bid price of the Company's security is at least $1 per share for a minimum of 10 consecutive business days, the Company will regain compliance with this Nasdaq rule and this matter will be closed. This current notification from Nasdaq has no immediate effect on the listing or trading of the Company's ordinary shares, which will continue to trade on the Nasdaq Capital Market under the symbol "SPCB". The Company will actively monitor the closing bid price of its ordinary shares between now and December 12, 2022 and intends to consider all available options to resolve the deficiency and regain compliance within the additional compliance period provided.

12:23 EDT Compass Inc trading resumes

12:14 EDT Redfin CEO says layoffs come as May demand 17% below expectations - Redfin CEO Glenn Kelman said in a letter to staff that was published on the company's website that the company is asking 8% of its workforce to leave, or about 6% if you include the people of RentPath and Bay Equity. "To all the departing people who put your faith in Redfin, I'm sorry we can't keep our commitment to you," Kelman said. "With May demand 17% below expectations, we don't have enough work for our agents and support staff, and fewer sales leaves us with less money for headquarters projects. We're offering laid-off colleagues ten weeks of base salary, with an additional week of pay for every 12 months of service beyond one year, capped at 15 weeks of pay. For agent and support roles, severance pay includes the estimated value of productivity bonuses or sales bonuses. We'll also pay departing employees the cost of extending our healthcare coverage for three months. This should give you until the end of the summer to find work. A layoff is always an awful shock, especially when I've said that we'd go through heck to avoid one, and that we raised hundreds of millions of dollars so we wouldn't have to shed people after just a few months of uncertainty. But mortgage rates increased faster than at any point in history. We could be facing years, not months, of fewer home sales, and Redfin still plans to thrive. If falling from $97 per share to $8 doesn't put a company through heck, I don't know what does." Kelman added that the layoffs are the result of revenue shortfalls and "not in the people being let go." "Because for every project we start, we have to think about another we'll stop," the CEO said. "We've already built tools for teams to work together on a transaction, so we need fewer engineers to add to those tools. We'll spend less on analytics and user research. When we were turning away tens of thousands of customers in 2020 and 2021, we had to hire a thousand employees a month to catch up, requiring berserk levels of recruiting, training and licensing. There's no avoiding that those groups will be hardest hit today." Reference Link

12:07 EDT Caterpillar to relocate global headquarters to Dallas-Fort Worth area - Caterpillar announced it will move its global headquarters to the company's existing office in Irving, Texas, from its current location in Deerfield, Illinois. "Caterpillar has had a presence in Texas since the 1960s across several areas of the company. Illinois remains the largest concentration of Caterpillar employees anywhere in the world. The company will begin transitioning its headquarters to Irving in 2022," Caterpillar stated. "We believe it's in the best strategic interest of the company to make this move, which supports Caterpillar's strategy for profitable growth as we help our customers build a better, more sustainable world," added Chairman and CEO Jim Umpleby.

12:05 EDT Odyssey Marine provides update on financing transaction - Odyssey Marine Exploration provided a corporate update. "On Friday, we closed a registered direct offering of equity securities that will allow us to continue to deleverage our balance sheet while also providing capital for Odyssey's ongoing operations through the next nine to 18 months, bridging us to anticipated significant cash flows. We expect this financing to carry Odyssey through a decision on our NAFTA arbitration and provide the cash to self-fund a portion of the NAFTA litigation," stated Mark Gordon, Odyssey Chairman and CEO. "Additionally, the capital will provide for targeted investments in key mineral projects that will help power the Green Economy." The financing transaction provides approximately $15.0 million of net proceeds to Odyssey and provides the following benefits: Ability to self-fund some NAFTA litigation expenses versus utilizing existing litigation funders. This $2B+ claim against Mexico under NAFTA relates to the illegal denial of the environmental permit for a subsidiary's offshore phosphate project. Having completed hearings before the NAFTA Tribunal, Odyssey management is increasingly confident in the outcome of the litigation and would prefer to self-fund expenses to maximize the amount of any award to Odyssey. Allows for final payment of $2.5 million to satisfy a portion of the indebtedness associated with our legacy business. As previously announced, $14.5M in principal and accrued interest outstanding under various notes were repaid with $9.5M in cash and shares of stock. The final $2.5M included a conversion feature that will no longer be exercisable. Even after considering the pricing associated with this transaction, the payoff is accretive to stockholders with Odyssey achieving a 34% discount on the overall retirement of $14.5M in debt. Proceeds from the financing will also be available to repay a portion of the indebtedness owed to Minera del Norte, S.A. de C.V. Provides operating capital for Odyssey through the next nine to 18 months. Within this timeframe, Odyssey expects to have a decision on our +$2B NAFTA case. Additionally, a significant cash inflow from proceeds of a salvage contract that is now progressing through the UK court where a favorable determination is expected within several months. The proceeds from this contract could provide another year or more of operating capital and/or additional deleverage of the company's balance sheet. Allows Odyssey to provide targeted investment into key mineral projects in South America and the Pacific Islands. Mineral validation is expected in these projects within the next six to twelve months, focusing on Phosphate, Cobalt, and Nickel. These investments are intended to increase the value of our mineral portfolio assets by moving the projects up the value curve. CIC, a company in which Odyssey currently holds a minority position, is expected to begin offshore exploration later this month, and current third-party investments into the project support a value for Odyssey's equity in CIC at over $60M. "The last time we completed a registered direct offering was 22 months ago. As forecasted, that transaction funded our operations through the completion of the NAFTA hearing, enabled us to expand our ownership in existing projects and invest in the development of new projects," explained Gordon. "Since that last equity raise, we removed $12.5M in debt from the balance sheet, increased our equity in the ExO project from 53.5% to 56.3%, increased our equity in the Lihir project from 79.9% to 85.6%, assisted CIC in their successful exploration license application and added two new projects to our portfolio that are being primed for the offshore exploration phase. We believe that this latest transaction will allow us to continue to increase the value of our diversified mineral portfolio and deleverage our balance sheet, building additional stockholder value."

12:02 EDT Apple announces partnership to present Major League Soccer matches - Apple and Major League Soccer, or MLS, announced that the Apple TV app will be the exclusive destination to watch "every single live MLS match," beginning in 2023. "This partnership is a historic first for a major professional sports league, and will allow fans around the world to watch all MLS, Leagues Cup, and select MLS NEXT Pro and MLS NEXT matches in one place - without any local broadcast blackouts or the need for a traditional pay TV bundle. From early 2023 through 2032, fans can get every live MLS match by subscribing to a new MLS streaming service, available exclusively through the Apple TV app. In addition to all of the match content, the service will provide fans a new weekly live match whip-around show so they never miss an exciting goal or save, and also game replays, highlights, analysis, and other original programming," the company and league announced. Complete details for the new service, including when fans can sign up, subscription pricing, specific details about the new MLS programming, an improved match schedule, broadcast teams, production enhancements, and pre- and postgame coverage - as well as all the ways fans will be able to enjoy MLS content across the Apple ecosystem - will be announced in the coming months, Apple stated.

12:00 EDT Antero Resources falls -9.5% - Antero Resources is down -9.5%, or -$4.04 to $38.55.

12:00 EDT United States Natural Gas Fund falls -16.7% - United States Natural Gas Fund is down -16.7%, or -$4.90 to $24.51.

12:00 EDT New Oriental Education rises 22.9% - New Oriental Education is up 22.9%, or $3.92 to $21.02.

11:58 EDT Transcode Therapeutics treatment of pancreatic cancer granted FDA orphan status - Transcode Therapeutics' treatment of pancreatic cancer was granted FDA orphan status, according to a post to the agency's website. Reference Link

11:36 EDT Bandai Namco's 'Elden Ring' back as best-selling game in U.S. in May, says NPD - NPD analyst Mat Piscatella said Bandai Namco's (NCBDY) "Elden Ring" returned to the top of the best-selling titles chart in the U.S. for May 2022, after ranking 2nd in April. "Elden Ring" was the best-selling game of May on both Xbox (MSFT) and Steam, while placing 2nd on PlayStation (SONY). It remains the best-selling game of the year. Saber Interactive's "Evil Dead: The Game" was the 4th best-selling game of May and was the only new release to appear among the top 50 best-selling games of the month. Bethesda's "The Elder Scrolls V: Skyrim" returned to the top 20 best-selling titles chart for the first time since ranking 20th during November 2017. Steam accounted for nearly half of the title's May 2022 dollar sales. Other games in the top ten in sales for the month include Warner Bros. Interactive's (WBD) "LEGO Star Wars: The Skywalker Saga," Nintendo's (NTDOY) "Nintendo Switch Sports," Sony's "MLB The Show 22," Activision's (ATVI) "Call of Duty: Vanguard," and Nintendo's "Kirby and the Forgotten Land." Other publicly traded companies in the video game space include Electronic Arts (EA), Take-Two (TTWO), Tencent (TCEHY), Ubisoft (UBSFY), Capcom (CCOEY), and Square Enix (SQNXF). Reference Link

11:06 EDT Boeing reports 23 gross commercial airplane orders in May - Boeing reported 23 commercial airplane gross orders for the month of May. Boeing delivered 35 aircraft in the month, the company reported on its website. Boeing lists 171 year-to-date orders net of cancellations/conversions and 107 year-to-date new orders. Reference Link

10:54 EDT Adial Pharmaceuticals awarded U.S. patent for genetic diagnositc with AD04 - Adial Pharmaceuticals announced patent number 11,351,154 was issued on June 7, 2022, by the U.S. Patent and Trademark Office. The patent covers the use of the Company's genetic diagnostic panel in combination with the Company's lead product, AD04, for the treatment of alcohol use disorder and Opioid Use Disorder. This patent expands coverage of previously issued patents to include the measurement of the genetic biomarkers for all of the targeted genotypes utilizing the Company's proprietary diagnostic test.

10:39 EDT Aziyo Biologics Inc (Class A Stock) trading halted, volatility trading pause

10:27 EDT Blink Charging sees closing SemaConnect deal in June - The deal includes upfront cash consideration of $40M and deferred cash consideration of $40M, as well as $120M of Blink common stock issued to SemaConnect shareholders representing an estimated 7.5M shares. Comments taken from investor presentation slides.

10:24 EDT European Sustainable Growth Acq Corp trading resumes

10:19 EDT European Sustainable Growth Acq Corp trading halted, volatility trading pause

10:06 EDT Gilead makes new investment in Turkey for Hepatitis, HIV Drugs - According to Turkey's Investment Office, Gilead Sciences "took a decision to invest in Turkiye's Pharmactive to produce HIV and Hepatitis drugs in Turkiye. According to a statement released by Gilead Sciences, the investment is expected to reach TRY 350 million, including the machinery and equipment for local manufacturing, capital increase and transfer of know-how as part of the partnership agreement signed between Gilead and Pharmactive back in 2019." The statement also emphasized, "With this new investment, Turkey is aimed to transform into a potential pharmaceutical export hub. The partnership will enable Turkey to manufacture new therapies and will eliminate the need of importing pharmaceuticals worth of $250 million until 2024." Reference Link

10:01 EDT United-Guardian completes strategic alternatives review, sees no opportunities - United-Guardian announced that it has completed the formal review of strategic alternatives that it initiated in January, and concluded that there were no opportunities presented to the company that the Board of Directors believed would be in the best interests of the company to pursue at the present time. While the active efforts that began in January will be suspended, the company will continue to explore opportunities to grow the company's core businesses, and will consider any opportunities for strategic alternatives that may be brought to the company in the future that the Board believes would be in the best interest of the company and its shareholders.

10:00 EDT Amwell falls -8.6% - Amwell is down -8.6%, or -34c to $3.63.

10:00 EDT United States Natural Gas Fund falls -16.6% - United States Natural Gas Fund is down -16.6%, or -$4.89 to $24.52.

10:00 EDT Continental Resources rises 14.1% - Continental Resources is up 14.1%, or $9.09 to $73.59.

09:57 EDT Applied Minerals receives purchase order for DRAGONITE halloysite clay - Applied Minerals has received an initial purchase order for 2,200 lbs. of its DRAGONITE halloysite clay for use as an additive in a chemical foaming agent application for polymers.

09:47 EDT Corporacion America Airport falls -5.3% - Corporacion America Airport is down -5.3%, or -32c to $5.66.

09:47 EDT United States Natural Gas Fund falls -11.9% - United States Natural Gas Fund is down -11.9%, or -$3.50 to $25.91.

09:47 EDT Continental Resources rises 14.2% - Continental Resources is up 14.2%, or $9.14 to $73.64.

09:45 EDT AeroClean Technologies Inc trading resumes

09:40 EDT AeroClean Technologies Inc trading halted, volatility trading pause

09:37 EDT Synaptogenix Inc trading halted, volatility trading pause

09:33 EDT CHS Inc. to build grain facility in Erskine, Minnesota - CHS will begin construction this summer on a new grain facility with 1.25 million bushels of additional storage capacity in Erskine, Minn. The facility is slated to be operational in the fall of 2023 and will help CHS expand operational capabilities and increase efficiency across its footprint. The new shuttle elevator will bring total capacity at the location to 4.55 million bushels of storage and will complement existing CHS grain, agronomy and energy assets and offerings for area producers. The new terminal is the latest in a series of investments throughout Minnesota and North Dakota by CHS. In keeping with its core value of safety, the company has placed priority on safety features and advancements to improve operating conditions.

09:31 EDT General Mills, Regrow Agriculture announce partnership - General Mills and Regrow Agriculture announced a multi-year partnership to monitor agricultural practices and their environmental impacts across 175M acres of farmland in North America, Europe, and South America. One hundred and seventy-five million acres represents General Mills' estimated supply sheds - the regions where the company sources its key ingredients, like wheat, oat, and dairy. Within the total acreage being monitored, General Mills sources its ingredients from roughly three million acres of farmland each year. Regrow Agriculture supports General Mills' commitments to advance regenerative agriculture on one million acres of farmland by 2030, reduce absolute greenhouse gas emissions - 60% of which are from agriculture - across its value chain by 30% by 2030, and ultimately achieve net zero emissions by 2050. General Mills will leverage Regrow Agriculture's software platform, Sustainability Insights, and its technology and data capabilities, including Operational Tillage Information System and DeNitrification-DeComposition, to monitor trends and estimate impacts where regenerative agriculture principles are being advanced on farmland.

09:26 EDT Despegar.com board approves repurchase of up to $40M in shares - Despegar.com announced that on June 13, the company's board of directors approved a new share repurchase program that enables the company to repurchase up to $40M of its shares. The 2022 share repurchase rogram becomes effective on June 14 and expires on August 12, 2022. "Share repurchases may be undertaken through a variety of methods, including pursuant to trading plans adopted in accordance with Rule 10b5-1 of the Exchange Act, or through open market or privately negotiated transactions, in accordance with applicable law," the company stated.

09:20 EDT Tyler expands its courts and public safety footprint in Ohio - Tyler Technologies announced that it has signed two agreements in Fairfield County, Ohio. The first is with the Fairfield County Probate and Juvenile Court for Tyler's Enterprise Justice suite, powered by Odyssey, and the second is with the Fairfield County Sheriff's Office for Tyler's Enterprise Public Safety suite, powered by New World. The Probate and Juvenile Court is currently operating a legacy case management system that is based on older technology and no longer serves the needs of the courts. The courts selected Tyler's Enterprise Justice and Enterprise Supervision solutions to improve case management, streamline court processes, and manage all supervision processes and pretrial services more efficiently. These SaaS solutions will run on Amazon Web Services , the world's most comprehensive and broadly adopted cloud offerings. This offering will bring added benefits to the courts that include increased availability and uptime of the products and enhanced security and compliance. This environment will also eliminate the need for the courts to build and maintain local servers. "We are excited to modernize our court operations with Tyler as we've outgrown our current case management solution," said Fairfield County Probate and Juvenile Court Judge Terre Vandervoort. "Deploying the solutions in the cloud gives us the added benefits of less strain on our internal IT resources and knowing we're always receiving the latest software updates."

09:17 EDT Beyond Meat announces availability of Cookout Classic in over 10,000 outlets - Beyond Meat is making plant-based burgers more accessible this summer grilling season with expanded availability of its Cookout Classic value pack. Since last summer, Beyond Meat has significantly expanded the distribution of Cookout Classic to over 10,000 stores nationwide including at Giant Food, Hannaford, Publix, ShopRite, Sprouts, Stop & Shop, Wegmans, Whole Foods Market, and select Albertsons, Kroger, Target and Walmart locations.

09:14 EDT AeroVironment awarded $6.17M Puma 3 AE contract - AeroVironment announced receipt of a $6.17M firm-fixed-price contract award for Puma 3 AE small unmanned aircraft systems, or SUAS, and spares on May 3 for the U.S. Marine Corps. Delivery is anticipated to be completed in July.

09:12 EDT Eguana Technologies receives + $7M micro inverter order - Eguana Technologies announced it has received its first micro inverter order from the Omega Group. The order, consisting of single, dual, and quad style micro inverters, totals nearly 26,000 units with a combined value of just over $7M. Initial bulk container shipments are currently in transit with installer and branch level fulfillment orders expected to commence shipping in the next 4 weeks. "We have an incredible opportunity in the US micro inverter market and feedback from our distribution partners has been very clear. There is significant demand for a fully integrated solar + storage solution with a recognizable brand to diversify the market and provide consumers with renewable energy choice" commented Eguana CEO Justin Holland. "Energy storage and residential rooftop solar will both play critical roles in transforming the power grid and providing desperately needed EV infrastructure, with our partner Omega we now have both readily available."

09:11 EDT Verizon to expand 5G Ultra Wideband availability using CBRS spectrum - Verizon (VZ), along with strategic partner Ericsson (ERIC), announced it has completed a 5G data session using CBRS General Authorized Access, GAA, spectrum. This trial indicates that Verizon and its vendors are ready to support 5G on both shared and Priority Access License, PAL, CBRS spectrum, which will supplement Verizon's current deployment of 5G service over C-band and mmWave spectrum. With 5G Ultra Wideband data usage having increased 249%, the expansion of 5G service onto this spectrum band will help meet customers' future needs. Historically, Verizon has used shared and licensed CBRS spectrum to supplement its low and mid band deployment of 4G LTE service and private network offerings. With this successful trial and CBRS licenses in markets across the nation, Verizon is positioned to expand its 5G network to this new spectrum in parallel with its ongoing 5G deployment on C-band. This expansion will support Verizon's core areas of growth and innovation across mobility, nationwide broadband, mobile edge compute and business solutions, the value market and network monetization.

09:09 EDT DraftKings, BetBlocker announce intercontinental collaboration - DraftKings and BetBlocker announced their collaboration to advance awareness of, and access to, BetBlocker's acclaimed software. Consumers using BetBlocker are able to set restrictions on their gaming activities across all of their devices at no cost to them, and these restrictions will apply across thousands of gaming sites, whether regulated or not, anywhere in the world. "BetBlocker's contributions to safer play are commendable and DraftKings is pleased to team up with this enterprising and disruptive not-for-profit that is advancing responsible gaming in a comprehensive and consumer friendly way," said Chrissy Thurmond, Senior Director of Responsible Gaming, DraftKings. "We share BetBlocker's vision that technology and innovation are critical to promoting safer play, and we extend a warm welcome to BetBlocker as they build their footprint in North America, following widespread success across the pond." Developed in the U.K., BetBlocker is the first and only no-cost tool that enables individuals to set restrictions on their play on all of their personal devices.

09:08 EDT Wells Fargo CFO: Mortgage banking income could be down 50% from Q1 - Comments taken from the Morgan Stanley US Financials, Payments & CRE Conference.

09:07 EDT Verisk's Infutor to launch Infutor Identity Resolution - Infutor announced that it is launching Infutor Identity Resolution, an embedded application that will enrich and activate first-party data natively in the Snowflake Data Cloud. The Infutor Identity Resolution application is built using Snowflake's Native Application Framework, currently in private preview, which enables application developers to build applications using Snowflake core functionalities, globally distribute them on Snowflake Marketplace, and deploy them within a customer's Snowflake account. With Snowflake, the Data Cloud company, Infutor is helping joint customers activate their first-party data in a secure environment that easily integrates with their other data sets. With data clean room capabilities, brands, agencies, platforms and publishers can build better 360-degree views of their customers in a secure and privacy-forward environment. This is especially critical for performance marketers who need to maintain the highest levels of data privacy.

09:05 EDT Wave Life Sciences announces pricing of $70M underwritten offering - Wave Life Sciences announced the pricing of an underwritten offering of 25,464,483 of its ordinary shares at an offering price of $2.15 per ordinary share, and, to RA Capital Management, L.P. in lieu of ordinary shares, pre-funded warrants to purchase up to 7,093,656 ordinary shares at an offering price of $2.1499 per pre-funded warrant, which represents the per share offering price for the ordinary shares less the $0.0001 per share exercise price for each pre-funded warrant. The per share offering price for the ordinary shares represents a premium of 7.5% over the closing price for Wave Life Sciences' ordinary shares on June 13, 2022. The pre-funded warrants contain a blocker provision which provides that they are only exercisable upon receipt of shareholder approval or if such exercise would not cause the aggregate number of ordinary shares or the combined voting power of total securities, in each case, beneficially owned by the holder to exceed 19.99% of the number of ordinary shares or total securities, respectively, outstanding immediately after giving effect to the exercise. Gross proceeds to Wave Life Sciences from the Offering are expected to be approximately $70.0 million, before deducting underwriting discounts and commissions and offering expenses. All of the securities in the Offering are being sold by Wave Life Sciences. The Offering is expected to close on or about June 16, 2022, subject to customary closing conditions. RA Capital and other notable growth and life science investors participated in the Offering.

09:05 EDT Gevo's northwest Iowa RNG project hits major milestone - Gevo (GEVO) announced that its renewable natural gas, RNG, project in Northwest Iowa has been producing biogas and is now upgrading and injecting RNG into the natural gas pipeline. The RNG Project generates renewable natural gas captured from dairy cow manure. The manure for the RNG Project is supplied by three dairy farms located in Northwest Iowa totaling over 20,000 milking cows. When at full operational capacity, the RNG Project is expected to generate approximately 355,000 MMBtu of RNG per year, which will be transported and sold in California. BP Canada Energy Marketing Corp. (BP) and BP Products North America will market the RNG in California on behalf of Gevo, and Gevo expects that the RNG Project will generate between $16M and $22M of Project EBITDA per year beginning by 2023. Gevo expects to be able to get approval for Renewable Identification Numbers through RFS and carbon credits from LCFS later this year or next year.

09:04 EDT Fortinet releases inaugural sustainability report - Fortinet announced its inaugural Sustainability Report, detailing the company's sustainability strategic framework, initiatives, and key performance metrics. The company plans to share updated progress on an annual basis. Following a materiality assessment conducted in 2021 to identify and prioritize the Environmental, Social and Governance issues that are most significant to Fortinet's business and to its stakeholders, the company defined the following four main areas of impact: Innovating for a safe internet: Fortinet is committed to advancing cybersecurity, driving digital progress and creating a trustworthy and safe digital world. The company delivers on this commitment through innovation, community engagement and partnerships. Fortinet has continued to innovate on the industry's broadest portfolio of cybersecurity solutions adding eight new product families in 2021 only. Fortinet also regularly engages with numerous industry associations and groups, contributing to standardization and interoperability while also sharing actionable threat intelligence with organizations such as the Cyber Threat Alliance, the World Economic Forum's Center for Cybersecurity and INTERPOL. Through these partnerships, Fortinet is working to combat cybercrime and help mitigate future cyberthreats. Respecting the environment: Fortinet is committed to environmentally responsible behavior by reducing the footprint of its products and solutions, adopting responsible approaches to its daily business operations, and helping its broader value chain progress toward circularity. In 2021, Fortinet publicly announced its commitment to carbon neutrality by 2030 using renewable energy, energy and carbon efficiency methodologies, and emission offset programs. This target is relative to Scope 1 and Scope 2 emissions resulting from the company's owned facilities worldwide, in alignment with the Science Based Target Initiative. Fortinet's other environmental efforts include the introduction of biodegradable packaging to the company's first class of products, reduction of the company's waste and reduction in energy consumption. Through these initiatives, the company ensures that each generation of Fortinet products consume less energy than the prior generation. This is the case with the FortiGate F series, where energy consumption has been reduced by an average of 61%. Growing an inclusive cybersecurity workforce: Fortinet is committed to fostering a diverse, equitable and inclusive culture. Fortinet's team represents a broad range of cultures, demographics and professional backgrounds, enriching the company culture and driving its success. As part of its ongoing commitment to transparency and to bringing more women into the cyber workforce, the company has released its workforce data in 2021 and highlighted an increase of 71.6% on its women hires compared to 2020. Fortinet is also focused on reducing the cybersecurity skills gap across a wide and diverse range of audiences. The company is committed to raising awareness on the benefits of cybersecurity careers and improving opportunities for under-represented groups through its Education Outreach program and training offered through the Fortinet Training Institute. As a result, in 2021, Fortinet bolstered its commitment to address the cybersecurity skills gap by pledging to train one million people globally across the next five years. Promoting responsible business: Fortinet employs corporate governance practices to do business ethically and work diligently to ensure compliance with all laws and in respect of human rights. Those practices are overseen by Fortinet's Board of Directors and reviewed by our internal cross-functional Ethics Committee. We expect our employees, suppliers and partners to do their part in helping us build a highly ethical and reputable business by understanding and complying with all Fortinet's policies, including our anti-corruption policy, our Code of Business Conduct and Ethics and privacy policy. Fortinet has issued a dedicated Human Rights Policy to reinforce its commitment for responsible product use and ethical business across its value chain.

09:03 EDT Jamf Holding announces new updates for healthcare IT - Jamf rolled out new functionality to help healthcare and IT teams protect patient data and streamline clinical access for their Apple fleet. Jamf introduced a new Healthcare Listener workflow called App Refresh. App Refresh provides health systems deploying iPad and Apple TV a faster way to refresh specific app content and prepare a device for the next patient. The automated workflow uninstalls and reinstalls managed apps and in-house books from bedside devices - all without requiring a full device reset. App Refresh enhances the experience for patients by removing all iOS and tvOS Setup Assistant prompts that follow a device reset, and configures the device so it is ready for immediate use without any manual setup. For IT admins, the entire refresh workflow is shortened, the device remains online and managed by IT admins in Jamf Pro, and they have device visibility throughout the entire process. For organizations who wish to maintain a full device reset between patients, Healthcare Listener will retain its current automated device wipe capabilities, allowing flexibility for all environments. The Jamf Parent app has existed for years as a way for parents and guardians to have limited management of their child's school-issued iPad from their own personal device. With a new Jamf Parent setting in Jamf Pro, there is now a workflow that extends Jamf Parent to provide temporary wireless remote management capabilities of a patient's hospital-issued device. A parent or guardian can pair their personal device with the hospital's managed iPad through a QR code pairing process within the Jamf Parent app. Now, with the power of MDM, parents have the ability to limit patient apps, device functionality, and reset the device passcode. When Healthcare Listener or Jamf Reset remotely wipes the patient's device, the Jamf Parent app session is disconnected automatically. This requires no work from IT and ensures parent devices are only able to perform management actions on hospital owned devices while the patient is admitted. Great for pediatric care, behavioral health and other scenarios, this functionality makes it simple and secure to personalize bedside Apple technology to match the specific needs of each patient. Single Login with Jamf Setup and Jamf Reset is a preview workflow designed to provide a simple and productive end-user experience for employees who use shared iOS and iPadOS devices.

08:53 EDT FedEx adds total shareholder return performance metric to executive comp plans - FedEx announced what it calls "a series of long-planned business and corporate governance actions consistent with the company's efforts to drive long-term value creation for all stakeholders." As part of this announcement, FedEx reports that its cash-based long-term incentive program for fiscal 2023 through 2025 includes an additional performance metric tied to FedEx's total shareholder return relative to a broad market index. The LTI program also includes a capital expenditures as a percentage of revenue performance metric. "The CapEx/Revenue target metric in the new LTI program is lower than in prior years to align with FedEx's capital plans for fiscal years 2023 through 2025, and the company expects to further lower its capital intensity in subsequent years. These changes are specifically designed to make management compensation more directly tied to delivering outstanding TSR and long-term value creation," FedEx stated.

08:44 EDT Cenntro Electric, Princeton NuEnergy enter lithium-ion battery recycling deal - Cenntro Electric and Princeton NuEnergy announced a strategic partnership letter of intent for spent Lithium-ion battery feedstocks for recycled cathode materials and byproducts with Cenntro. The intent of the partnership is to drive end-to-end sustainability in the EV sector using advanced lithium-ion battery-powered vehicles and PNE recycling technology to reach net-zero emissions.

08:42 EDT Energy Recovery awarded SWRO contracts totaling over $8.2M - Energy Recovery announced three contract awards totaling over $8.2 million to supply its PX Pressure Exchanger energy recovery devices to seawater reverse osmosis desalination facilities in Asia. The orders are expected to be fulfilled by the end of Q3 of 2022. When completed, Energy Recovery estimates the plants will prevent nearly 180,000 metric tons of carbon dioxide emissions each year, the same amount of emissions produced by over 39,000 passenger cars in the same time period. Once these contracts are completed, Energy Recovery will support the production of over 4 million cubic meters of water per day in Asia.

08:41 EDT Vitru releases 2021 sustainability report - Vitru announces that has released its second annual sustainability report outlining the Company's environmental, social, and governance initiatives and progress. The 2021 Sustainability Report details Vitru's recent achievements in areas such as talent attraction, retention, and development as well as its efforts towards diversity. The report also provides an approach to our initiatives and results, focused on our business model, strategies, overviews for the future, and the Company's potential to create value to our stakeholders.

08:38 EDT Intrado introduces Sonic G3 Edge Compute - Intrado Corporation, which is controlled by affiliates of certain funds managed by Apollo Global Management, announced the launch of Intrado Sonic G3 Edge Compute, an appliance that gives Public Safety Answering Points, PSAPs, the flexibility and mobility to take 911 calls from virtually any location and provides 4G/5G connectivity redundancy and survivability in the event of an outage. Part of Intrado Power Access, the Sonic G3 works in tandem with the Company's trusted Power 911 call-handling software and with the newest addition to the suite, Power 911 Web, the just-released browser-based version. The Sonic G3 is the latest update to Intrado's Sonic G series.

08:38 EDT American Noble Gas provides update on drilling operations in farm-out agreement - American Noble Gas is pleased to provide an update on its drilling and completion operations regarding AMGAS's participation in its previously announced farm-out agreement to develop its oil and gas and brine interests in the Hugoton Field in Haskell and Finney Counties Kansas. The initial well was successfully drilled and logged indicating the potential discovery of substantial new reserves within the Hugoton Gas Field which the Company believes could reinvigorate the Hugoton Gas Field, the largest conventional onshore natural gas and helium field in North America. The initial well in which AMGAS has acquired a 40% participation together with three other venture partners was spud on May 7, 2022 with production casing set after testing and completion logs identified at least two potential zones with substantial gas and helium reserves. One of the zones of particular interest revealed a gas show across it. This particular zone was below previous completion attempts in a neighboring well and the completion logs of the zone revealed indications of permeability. The other zone that was previously completed in a neighboring well appeared to release gas while drilling indicating that gas reserve potential exists. The initial well was successfully perforated last week across two lower intervals of the Chase group of formations. The fracture stimulation has been designed to include at least two stages, the first of which will commence on or about June 20, 2022. This stimulation will consist of sand and nitrogen-based foam across the existing perforated intervals. The second stage will be performed across an upper interval to be perforated shortly after the first frac stage. The Company expects data on flow rates and gas composition the first week of July. Electricity and pipeline infrastructure are currently being prepared to connect the new well to produce the potential methane and helium gases and for disposal of produced water. AMGAS and its Venture partners intend to complete the well as expeditiously as possible subject to potential adverse weather conditions and the availability of raw materials and oil and gas service companies. The Company will continue to apprise investors as additional information becomes available.

08:36 EDT Duck Creek Technologies highlights partnership with ODB by MCG - Duck Creek Technologies announces a new partnership with ODG by MCG. This partnership will allow carriers to make educated decisions about the claims handling process while they aim to understand the expected cost and duration of an injury for an injured worker. Duck Creek Claims and its injury management component enables vendors such as ODG by MCG to integrate within its Evidence Based Disability Accelerator solution. "Our technology is made up of one system that processes all workers comp claims," said Andy Yohn, Vice President of Product Management at Duck Creek Technologies. "This singular solution increases efficiency and enables a better experience with more seamless partner integrations and application capability. From finding appropriate medical treatment, to calculating indemnity benefits, and streamlining the processing of medical invoices", Duck Creek Claims is committed to supporting carriers and their customers through the whole process. By partnering with ODG by MCG, we are eager to help workers return to work after a claim and to emphasize the overall health of workers."

08:35 EDT FedEx increases quarterly dividend by 53% to $1.15 per share

08:35 EDT FedEx announces cooperation agreement with D. E. Shaw, to add 3 directors

08:33 EDT Vivos Therapeutics announces results from retrospective study at SLEEP 2022 - Vivos Therapeutics announced that the Company presented positive results from a retrospective study with Vivos patients at this year's SLEEP 2022, the annual meeting of the Associated Professional Sleep Societies, a joint venture of the American Academy of Sleep Medicine and Sleep Research Society. On June 6, 2022, Dr. Seth Heckman, Vivos Medical Advisory Board member, led a presentation, titled, "Non-Surgical Maxillary Expansion Using A Novel Oral Appliance System." The presentation highlighted the results of 786 patients who underwent treatment with Vivos' customized, proprietary oral appliances to treat dentofacial abnormalities and/or mild to moderate OSA and snoring in adults. The study participants experienced statistically significant increases in both transpalatal widths and airway volumes. The study results therefore show that use of these devices may result in maxillary and airway expansion, which are critical factors in healthy breathing. Vivos refers to its oral appliance therapy as the Complete Airway Repositioning and/or Expansion therapy. Additionally, a subset of 139 patients results showed a decrease in their Apnea Hypopnea Index by over 50 percent in 61.6 percent of the patients and decreased the overall OSA severity category in 56.8 percent of the patients. "In our published studies and presentations, we've shown that as many as 80% of OSA patients using our devices with a trained dentist dramatically improve their AHI scores, and as high as 34% of patients are restored to normal breathing and sleep patterns. Moreover, our data has shown no further intervention has been required, which is a critical differentiating factor between our appliance therapy and other treatments for OSA. In fact, we know of no other OSA treatment that can match this," stated Kirk Huntsman, Vivos Chairman and CEO. "Sleep apnea contributes to multiple physical and mental health issues that that most patients don't even realize which may include high blood pressure/ hypertension, heart failure, stroke, coronary artery disease, depression/anxiety, and many other life-threatening illnesses. With innovative modern technologies like CARE, highly invasive, lifetime inventions like CPAP machines and surgeries may no longer be the only answer for patients in need."

08:33 EDT Heron Therapeutics publishes study of ZYNRELEF - Heron Therapeutics announced the online publication of a new study evaluating the efficacy and safety of ZYNRELEF, bupivacaine and meloxicam, extended-release solution as the foundation of a perioperative non-opioid multimodal analgesic, or MMA, regimen in patients undergoing total knee arthroplasty, or TKA. ZYNRELEF is approved by the FDA for use in adults for soft tissue or periarticular instillation to produce postsurgical analgesia for up to 72 hours after foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures. The study was published in the Journal of Knee Surgery, a peer-reviewed journal. All patients in the study received ZYNRELEF with an MMA regimen consisting of a nonsteroidal anti-inflammatory drug, or NSAID, acetaminophen and a gabapentinoid. The study showed that more than 80% of patients did not experience severe pain at any individual time point through 72 hours after TKA surgery. 47% of patients took less than or equal to20 morphine milligram equivalents over the 72-hour postoperative period, 12% of patients remaining opioid-free through 72 hours. Additionally, 39% percent of patients were discharged without an opioid prescription and did not call back to the study site to request additional pain medication between discharge at 72 hours and the Day 11 follow-up visit. Patient satisfaction with pain management was very good with 88% of patients reported "good" or "excellent" pain control 24 hours following surgery, with all patients maintaining that same level of pain control at 72 hours. Approximately 61% of patients were ready for discharge by 12 hours after surgery and up to 69% by 24 hours. The use of ZYNRELEF 400mg/12mg in patients undergoing TKA with bupivacaine spinal anesthesia and scheduled MMA did not identify safety concerns, and there was no evidence of NSAID-related toxicity, suggesting that the MMA regimen did not impact the safety profile of ZYNRELEF. ZYNRELEF is the first and only therapy for postoperative pain management to be rigorously tested in Phase 3 studies and demonstrate superiority to bupivacaine solution. ZYNRELEF demonstrated superior, sustained postoperative pain relief for up to 72 hours and decreased the need for opioids, with more patients opioid-free compared to bupivacaine solution.

08:31 EDT DCP Midstream enters agreement to acquire Permian Basin for $160M - DCP Midstream announced that it has entered into a definitive agreement to acquire Permian Basin gathering and processing assets from Woodland Midstream II, a portfolio company of EIV Capital, in a transaction valued at $160M, subject to certain customary adjustments. The James Lake System's proximity to DCP's existing assets creates the opportunity for significant synergies, reducing the acquisition multiple over time. "We are very pleased to announce the agreement to expand our Permian gathering and processing business with assets that have connectivity to DCP's existing infrastructure and fit our long-term strategy of securing incremental volumes for our downstream assets," said Wouter van Kempen, chairman, president, and CEO. "After our record first quarter performance and recent investment grade rating, we consider this an exciting next step in strengthening our operating model, creating additional value for our stakeholders and driving improved reliability for our customers." This transaction is expected to be completed in the third quarter of 2022, subject to customary regulatory approvals. The transaction is expected to be funded using cash on hand and borrowings under DCP's existing bank facilities.

08:31 EDT Coinbase drops 7% to $48.60 after cutting 18% of workforce, JPMorgan downgrade

08:29 EDT Teck Resources announces early results of cash tender offer - Teck Resources announced the early results of the previously announced tender offer to purchase certain of its outstanding notes identified in Teck's Offer to Purchase. Teck also announced that it has amended the Tender Offer to increase the aggregate maximum principal amount of Notes that may be accepted for purchase in the Tender Offer from $500 million to $650 million. In addition to the Revised Aggregate Maximum Tender Amount amendment noted above, Teck amended the Tender Offer as follows: extended the Expiration Date to one minute after 11:59 p.m., New York City time, on June 28, 2022; and terminated the Tender Offer with respect to its 5.400% Notes due 2043, 5.200% Notes due 2042 and 3.900% Notes due 2030.

08:27 EDT Coinbase sees $40M-$45M in charges from cutting 1,100 jobs - Coinbase Global this morning announced a restructuring plan to manage its operating expenses "in response to current market conditions and ongoing business prioritization efforts." The plan involves a reduction of the company's workforce by approximately 1,100 employees, representing approximately 18% of its global workforce as of June 10, following which the company expects to have approximately 5,000 total employees as of the end of its current fiscal quarter on June 30. The company expects execution of the plan to be substantially complete in Q2. In connection with these actions, Coinbase estimates that it will incur approximately $40M to $45M in total restructuring expenses, all of which are future cash-based expenditures and substantially all of which are related to employee severance and other termination benefits. The company expects to recognize substantially all of these charges in Q2.

08:25 EDT HEXO enters into amending agreements with Tilray - HEXO Corp. announced that the Company has entered into an amending agreement to the previously announced transaction agreement with Tilray Brands and HT Investments MA. Separately, the Company announced that it has also entered into an amending agreement to the previously announced equity purchase agreement with 2692106 Ontario and KAOS Capital. On June 14, 2022, in view of current stock market conditions and in order to reduce closing risk related to the pre-amendment minimum liquidity closing condition, the Company entered into the Amending Agreement to the Transaction Agreement pursuant to which HEXO, Tilray Brands and HTI agreed to: reduce the minimum liquidity interim covenant and closing condition from USD$100,000,000 to CAD$70,000,000 with such amount to be determined after giving effect to a release of all conditions in any blocked accounts and restricted cash of the Company and its subsidiaries and including net cash proceeds expected to be received from the Company's captive D&O insurance policy; extend the Outside Date from July 1, 2022 to August 1, 2022 and to extend the date past which the Outside Date cannot be extended to November 30, 2022; extend the date by which the Company must use best efforts to obtain shareholder approval from June 15, 2022 to July 15, 2022; reduce the Amendment Share Price from USD$0.54 to CAD$0.40; amend the condition regarding Tilray's right to appoint nominees and an observer to the Company's board of directors such that Tilray will be entitled to appoint two directors and one observer to the Company's board of directors; amend and restate the Purchased Note to reflect a reduction in Tilray Brands' Conversion Price from CAD$0.85 to CAD$0.40; and amend and restate the Assignment and Assumption Agreement to reflect certain changes to the purchase price and consideration. Additionally, Tilray has irrevocably waived any non-compliance by HEXO with the minimum liquidity interim covenant contained in the Transaction Agreement for all periods prior to the date of the Amending Agreement for all purposes, including with respect to Tilray's ability to terminate the Transaction Agreement for any such non-compliance. The terms of the Transaction Agreement are otherwise unamended. The closing of the transactions contemplated by the Transaction Agreement and the amended and restated Assignment and Assumption Agreement remain subject to the satisfaction of a number of conditions, including: receipt of approvals from the Toronto Stock Exchange and the Nasdaq Stock Market LLC; receipt of shareholder approval from HEXO's shareholders; no material adverse effect having occurred in respect of HEXO; and receipt of all consents and approvals required by any regulatory authorities, including from the Competition Bureau. HEXO expects to file a supplement to its previously filed management information circular in due course. The Company also announces that, in view of the Company's current share price, the Investor has formally agreed, for a period of three months, to reduce the minimum price condition included in the Standby Agreement from the CAD$0.30 to CAD$0.10 per share. This will ensure the Company may, during such three month period, draw upon the financing commitment contemplated by the Standby Agreement even if its share price were to fall below CAD$0.30 per share. In addition, the Investor has agreed to allow the Company to commence the process of drawing upon the Standby Commitment immediately following receipt of necessary regulatory approvals without having to wait until the first five trading days of the next calendar month as previously contemplated by the Standby Agreement. Subsequent draws will continue to be available only during the first five trading days of any month during the term of the Standby Commitment. Given the current market and macro-economic conditions, the Company believes that this is a positive development that will help ensure that it can have immediate access to capital as contemplated by the Standby Agreement. The Company is not required to pay the Investor any additional consideration in connection with these amendments to the Standby Agreement.

08:21 EDT TransUnion, Bilt Rewards bring free rent payment reporting to renters - Renters in more than two million apartments will now be eligible for free rent payment reporting through a partnership between TransUnion and Bilt Rewards. Starting today, renters at GID Windsor-Communities, Veritas Investments, AvalonBay, Equity Residential and other multifamily properties within the Bilt Alliance network will be the first to receive access to free rent reporting. "We know that young renters are increasingly seeking rent reporting services to build their credit, and we fully expect this practice to become an industry standard," said Maitri Johnson, vice president of tenant and employment screening at TransUnion. "Through this partnership, we are helping to meet that market demand and fulfill TransUnion's commitment to financial inclusion." Aligned with Bilt's mission to improve the financial outcomes of renters, TransUnion will work with Bilt to include tenant rent payments within their consumer credit files, free of charge for both residents and landlords.

08:19 EDT Fluence Energy announces training platform for energy storage systems - Fluence Energy announced its new online training platform for Fluence energy storage systems: Fluence Academy. Fluence Academy is designed to increase the knowledge and skillsets of Fluence customers to help them effectively and efficiently manage energy storage systems. Fluence Academy is a self-paced online training program with over thirty courses that cover topics including system safety, preventative maintenance, reactive maintenance, and Fluence OS controls software. Fluence Academy offers training packages tailored to different user types and includes two levels of advanced maintenance certifications.

08:18 EDT Outlook Therapeutics confirms status of BLA submission for ONS-5010 - Outlook Therapeutics is providing an update on its Biologics License Application, BLA, submission for ONS-5010 / LYTENAVA for the treatment of wet age-related macular degeneration. As previously announced, Outlook Therapeutics submitted its BLA for ONS-5010 to the FDA in March 2022 and subsequently voluntarily withdrew its submission in May 2022 to provide additional information requested by the FDA. Following receipt of further correspondence from the FDA, Outlook Therapeutics has confirmed the additional information necessary to re-submit the BLA for ONS-5010. C. Russell Trenary, President and Chief Executive Officer of Outlook Therapeutics, commented, "The additional correspondence from the FDA confirms our commitment to our shareholders to re-submit a completed BLA to FDA by September of this year. As stated previously, we believe the results from our clinical trials demonstrated safety and efficacy and we are on-track to re-submit this BLA and, if approved, to deliver the first FDA-approved ophthalmic formulation of bevacizumab to the retina community."

08:16 EDT Pacira reports preliminary sales of $46M for May - Pacira BioSciences reported preliminary unaudited net product sales for EXPAREL and iovera for the month of May 2022. EXPAREL net product sales were $44.9 million, compared with $41.2 million for May 2021. The company also reports average daily growth rates for EXPAREL to account for differences in the number of selling days per reporting period. EXPAREL average daily sales for the month of May 2022 were 104 percent of May 2021. The number of EXPAREL selling days were 22 in May 2022 and 21 in May 2021. Net product sales of iovera degrees were $1.1 million for the month of May 2022, compared with $1.0 million for May 2021. "EXPAREL utilization continues to expand and support the market's transition to outpatient sites of care. Importantly, EXPAREL is consistently and significantly outperforming the elective surgery market's recovery, which is facing pockets of persistent pandemic-related disruptions and labor shortages," said Dave Stack, chairman and chief executive officer of Pacira BioSciences. "In addition, ZILRETTA is performing well, with a steady increase in new users and more than 220 accounts added year-to-date. For iovera degrees , the broad rollout of our Generation-2 device is now underway, and we expect the product to return to more robust year-over-year growth later this year. Our state-of-the-art training facility in Tampa continues to broaden interest in all three products and accommodates the market's growing demand for best-practice education around regional blocks. With the established growth and long-term potential of our product portfolio, we remain highly confident in our outlook for strong revenue and earnings growth as we further cement our leadership position in non-opioid pain management," continued Mr. Stack.

08:13 EDT aTyr Pharma announces FGFR4 as receptor target for AARS tRNA synthetas fragment - aTyr Pharma announced that new findings from its platform will be presented in a poster today at the Keystone Symposia Tissue Fibrosis and Repair: Mechanisms, Human Disease and Therapeutics in Keystone, CO. The poster presents findings from aTyr's innovative tRNA synthetase platform, whereby selected fragments of Alanyl-tRNA Synthetase, AARS, and Aspartyl-tRNA Synthetase were found to bind to the surface of specific human cell types via novel binding partners. Additionally, the target receptor of the fragment AARS-1 was identified as fibroblast growth factor receptor 4, indicating that AARS-1 may have therapeutic potential in fibrosis, inflammation and cancer. Moreover, the methods utilized in the study can be further employed to identify and validate new molecular targets from aTyr's tRNA synthetase platform. "We are very pleased that our novel approach to drug discovery has yielded the identification of a receptor target for yet another tRNA synthetase from our platform," said Sanjay S. Shukla, M.D., M.S., President and CEO of aTyr. "The target receptor identified for the fragment AARS-1, FGFR4, is involved in many cellular processes including cell proliferation, differentiation and tissue repair. FGFR4 is known to play a role in diseases related to inflammation and fibrosis, including conditions where unchecked fibrosis can precede the development of certain cancers. We look forward to further interrogating the interaction between AARS-1 and FGFR4 and the implications for disease in order to explore this synthetase fragment as a potential pipeline candidate."

08:12 EDT Baosheng Media regains compliance with Nasdaq minimum bid price requirement - Baosheng Media Group announced that the Company received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market on June 9, 2022, informing the Company that it has regained compliance with the Nasdaq's minimum bid price requirement and the matter is closed. On February 1, 2022, the Company was notified by Nasdaq its failure to maintain a minimum bid price of $1.00 per share for 30 consecutive business days under Nasdaq Listing Rules 5550(a)(2) and 5810(c)(3)(A), and was given a 180-day extension, or until August 1, 2022 to regain compliance. Effective May 24, 2022, the Company effected a 1-for-3.2 reverse stock split, which was reflected with Nasdaq and in the marketplace at the opening of business on May 25, 2022. The Notification Letter the Company received from Nasdaq on June 9, 2022 noted that the Company evidenced a closing bid price of its ordinary shares at or greater than the $1.00 per share minimum requirement for the last 10 consecutive business days, from May 25 through June 8, 2022. Nasdaq stated that accordingly, Baosheng has regained compliance with Nasdaq Listing Rule 5550(a)(2).

08:11 EDT NextEra Energy announces amendment in services agreement with NextEra Energy - NextEra Energy Partners (NEP), will host an investor conference today, June 14, in New York City. Among other things, NextEra Energy Partners is announcing that it has entered into a third amended and restated management services agreement with an indirect wholly owned subsidiary of NextEra Energy (NEE) to structurally modify the partnership's incentive distribution rights, or IDR, fees, whereby fees will be flattened at approximately $157M per year. Beginning in the Q3, NextEra Energy will receive a fixed fee of approximately $157M, with no incremental IDRs on distribution per unit growth above an annualized rate of $3.05 per common unit. The approximately $157M fee is predicated on NextEra Energy Partners delivering limited partner distributions at an annualized rate of at least $3.05 per common unit to all unitholders. If annualized limited partner distributions are below $3.05 per common unit, then the existing fee structure shall apply. The changes to the IDR fees are expected to provide more cash available to limited partner unitholders, require fewer asset additions to achieve growth objectives, extend NextEra Energy Partners' distribution growth runway and provide the partnership with more flexibility to finance its growth over the coming years.

08:10 EDT Happy Nation launches first metaverse experience via Roblox integration - Happy Nation, the newest brand from Victoria's Secret & Co, announced its debut in the metaverse via an immersive integration on Roblox. The integration features a virtual Happy Nation hub with three obstacle courses, each themed to reflect Happy Nation's core pillars of being friendly to the planet, empowered to give, and connected to our community, including a play-to-donate partnership with philanthropic partner Undies for Everyone.

08:09 EDT Hepion Pharmaceuticals appoints Aspeslet as Chief Operating Officer - Hepion Pharmaceuticals announced the appointment of Launa Aspeslet, PhD, RAC, as Chief Operating Officer. Dr. Aspeslet was most recently the CEO of Translational Research in Oncology.

08:07 EDT Armstrong World names Calzaretta as next Chief Financial Officer - Armstrong World Industries announced the appointment of Christopher Calzaretta to succeed Brian MacNeal as its next chief financial officer, CFO, effective Aug. 1, 2022. As CFO, Calzaretta will oversee the company's finance organization, including accounting and reporting, treasury, internal audit, tax and investor relations, and will report to Vic Grizzle, AWI president and chief executive officer. Calzaretta joined AWI in 2018 as vice president of Finance, Americas. AWI previously announced that MacNeal would be retiring in 2022. After Calzaretta assumes his new role as CFO, MacNeal will continue in an advisory role through Sept. 1, 2022, in order to support a smooth transition.

08:07 EDT Chipotle launches loyalty program, Chipotle Rewards, in Canada - Chipotle Mexican Grill announced it has officially launched its loyalty program, Chipotle Rewards, in Canada. This is the latest advancement in Chipotle's efforts to make the brand more accessible and to strengthen the relationship with its Canadian community. Chipotle implemented its U.S. loyalty program in 2019 and in only three years, 28 million members have enrolled, making it among the fastest growing loyalty programs in the history of the restaurant industry.

08:06 EDT Acasti Pharma announces issuance of additional patents for GTX-104, GTX-101 - Acasti Pharma announced that three composition of matter patents for GTX-104 were issued by The United States Patent and Trademark Office, the Japanese Patent Office, and the Australian Patent Office. Additionally, one new patent for GTX-104 was awarded by the Indian Patent Office. These granted patents are all valid until 2037. GTX-104 is a novel formulation of nimodipine for IV infusion to treat patients suffering from Subarachnoid Hemorrhage, which is caused by a ruptured aneurysm and is estimated to affect about 110,000 patients per year, in the US and Europe. In addition, the Canadian Intellectual Property Office has issued a notice of allowance for a composition of matter patent for GTX-101, a topical spray of bupivacaine targeting Postherpetic Neuralgia, PHN. The granted patent is valid until 2036. Jan D'Alvise, Chief Executive Officer of Acasti, stated, "We are pleased to report that our progress in the clinic is being matched by our progress protecting our intellectual property, both in North America and internationally. We are happy to highlight that we now hold 5 U.S. patents for GTX-104. GTX-101 could provide significant benefits over the current standard of care including greater convenience, faster onset of action and longer duration of pain relief and we are pleased to see that we have additional IP coverage in Canada. We expect that a single-dose clinical trial will be launched soon to study the PK profile of GTX-101 in healthy volunteers," D'Alvise concluded.

08:05 EDT Lipocine granted patent by USPTO for CNS and liver programs - Lipocine announced that the U.S. Patent and Trademark Office, or USPTO, has granted US patent 11,337,987 for "Compositions and Methods for Treating Central Nervous System, or CNS, Disorders" and US patent 11,370,811 for "Testosterone Dodecanoate Compositions and Methods of Preparation and Use". "We are pleased to have new patents granted in support of our innovative programs to treat liver and CNS disorders," said Mahesh Patel, Chairman, President, and CEO of Lipocine.

08:05 EDT OrthoPediatrics enters agreement to acquire Pega Medical for $33M - OrthoPediatrics announced they have entered an agreement to acquire Pega Medical, including its Fassier-Duval Telescopic Intramedullary System designed for patients suffering from Osteogenesis Imperfecta and other bone deformities. David Bailey, Chief Executive Officer of OrthoPediatrics, commented, "We are excited to announce the agreement to acquire Pega Medical. Similar to OrthoPediatrics, the Pega organization has been focused exclusively on addressing unmet needs for children whose lives have been impacted by musculoskeletal disorders and diseases. Their product offerings include novel technologies to treat some of the most unique conditions in pediatric orthopedics. We are grateful for the leadership and vision of the Pega team, and founder Ariel Dujovne in particular. I am looking forward to building on his legacy and our shared cause of helping even more KIDS with orthopedic conditions!" OrthoPediatrics will acquire Pega Medical in a transaction valued up to $33M. Under the terms of the agreement, OrthoPediatrics will acquire Pega Medical for an upfront cash payment of $31M plus $2M in stock - which includes certain restrictions for three years.

08:02 EDT Blink Charging announces agreement to acquire SemaConnect for $200M - Blink Charging announced the signing of a definitive agreement to acquire SemaConnect for $200M, subject to certain customary adjustments for working capital. The cash and common stock transaction will add nearly 13,000 EV chargers to Blink's existing footprint, an additional 3,800 site host locations, and more than 150,000 registered EV driver members. Blink will benefit from SemaConnect's in-house research & development, hardware design, and manufacturing capabilities. "This is a transformative acquisition for the EV charging industry and for Blink. SemaConnect is an established and well-known EV charging company with a proven track record of success, strong relationships with its site host partners in both the public and private sectors, and best-in-class technical capabilities," said Michael Farkas, Founder and CEO of Blink Charging. "SemaConnect has a robust hardware product line-up which complements Blink's extensive software product offerings. This includes our multi-language and multi-currency network, allowing Blink to have an EV charging station for any location across more than 20 countries and expanding," said Farkas. "In addition, we are particularly excited about the DCFC charger being developed by SemaConnect. These efforts allow Blink to significantly accelerate our DCFC speed to market while drastically reducing our R&D costs," said Farkas.

07:59 EDT Signify Health opens new regional service center in Oklahoma City - Signify Health announced the official opening of its new regional service center in Oklahoma City. The company will mark the opening of its 25,000 square-foot site with a ceremonial ribbon cutting event with state and local government representatives, business community leaders, and employees.

07:48 EDT Draganfly deploys Situational Assessment Drones to Ukraine - Draganfly announced that the Company, in partnership with Coldchain Delivery Systems has completed deployment and training of its first two Situational Assessment Drones to Revived Soldiers Ukraine . The Situational Assessment Drones were received by Iryna Vashchuk Discipio, President of RSU, and members of her staff, including pilots, at a facility in Poland on June 10, 2022. The drones were then transported to Ukraine, where the Company's experienced pilots conducted a thorough virtual training with RSU's drone operators. Draganfly has selected AeroVironment's Quantix Mapper hybrid vertical take-off and landing drone to serve as the Company's Situational Assessment Drone. Working with AeroVironment in 2020, the versatile remotely piloted aircraft system became the fifth aircraft in Draganfly's fleet to meet Transport Canada's safety assurance certification for RPAS advanced flight operations.

07:46 EDT Jacobs selected by Hartsfield-Jackson Atlanta International Airport - Jacobs was selected by Hartsfield-Jackson Atlanta International Airport, or ATL, to provide asset management consulting and professional services to develop a strategy for the operations, maintenance, modernization and future growth of physical assets throughout its 4,700-acre campus. Under this contract, Jacobs will assess the Department of Aviation's current asset management program; develop strategies, processes and asset management plans; assess the condition of facilities; and provide support and training for enterprise asset management systems. Jacobs' consulting team will integrate program elements into a comprehensive asset management program to bring measurable improvements in operational performance, sustainability, risk mitigation resiliency, investment planning and total cost of ownership.

07:42 EDT Pressure BioSciences announces publication highlighting Ultra Shear Technology - Pressure BioSciences announced a pivotal peer-reviewed scientific publication highlighting the use of PBI's patented Ultra Shear Technology platform in the production of protein-enriched milk containing a novel emulsified plant-protein suspension. J.J. Janahar, et al., from The Ohio State University College of Food, Agricultural, and Environmental Sciences in a study published in the high impact journal Food Hydrocolloids, Volume 131, reported that UST successfully created stable suspensions of milk-pea protein blends in microscopic particle sizes - the objective required for commercially-suitable products, and a significant achievement that could not be reached through existing high-pressure processing or thermal processing techniques alone. Efforts to produce satisfying, nutritionally-efficient and sustainable food options are driving one of the fastest growing food and beverage markets worldwide. Creating cost-effective and sustainable food alternatives that appeal to the expectations and preferences of global consumers has pushed researchers to examine many alternative protein enrichment sources, including the use of almonds, oats, soy, coconuts, peas, etc. Unfortunately, many of these protein sources lack the creaminess, texture, sweetness, or other attributes that drive consumer acceptance. The blending of plant and dairy components to achieve the desired consumer appeal presents enormous market opportunities. Pea protein is of particular interest because of its high nutritional value and low cost - but it is highly insoluble in water and thus has been minimally used in protein drinks to date. PBI's proprietary UST platform combines very high pressure and precisely controlled extreme shear forces to provide food scientists the toolset needed to successfully blend dairy and pea protein into a sensory-appealing, nutritional, and long-term stable plant protein-based beverage. PBI and Ohio State are co-leading a Food Industry Consortium whose mission is to introduce worldwide food and beverage companies to PBI's UST platform for the production of higher quality, longer shelf-life, and safer liquid foods and beverages. PBI's UST platform is the critical tool that enables and achieves targeted reductions and dependency on chemical additives or damaging heat relied upon in current processing methods. UST is pivotal in enabling the production of natural, organic, healthier, more nutritious, "clean-label" products that offer greater appeal to modern consumers.

07:40 EDT ContraFect announces presentation data on exebacase - ContraFect Corporation announces presentation data showing that the Company's lead product candidate, exebacase, which has been designated as a Breakthrough Therapy for development as a treatment for methicillin-resistant Staphylococcus aureus bloodstream infections by the FDA, was effective in a rabbit model of implant-associated osteomyelitis. These data were recently presented at the ASM Microbe Conference held in Washington, D.C. from June 9-13, 2022. Poster Presentations: "Locally Delivered Antistaphylococcal Lysins Exebacase or CF-296 is Active in Methicillin-Resistant Staphylococcus Aureus Implant-Associated Osteomyelitis." In this rabbit study, either exebacase or CF-296 was delivered locally into the medial tibia to treat osteomyelitis resulting from methicillin-resistant Staphylococcus aureus implantation. While all treatment groups showed activity, the greatest reductions in the concentration of bacteria colonies compared to daptomycin also were demonstrated with exebacase alone, or used in addition to daptomycin. Title: "Lysin Exebacase Has a Low Propensity for Resistance Development and Suppresses the Emergence of Resistance to Anti-Staphylococcal Antibiotics." These in vitro studies demonstrate the low propensity for the development of resistance to exebacase in both MRSA and methicillin-sensitive S. aureus strains. 28-day serial passage resistance assays demonstrated that the minimum inhibitory concentration of exebacase was not increased against MRSA and MSSA. In comparison, 28-day serial passage studies of daptomycin and vancomycin, and oxacillin, demonstrated the emergence of resistance to each of these standard of care antibiotics as evidenced by the need for greatly increased concentrations in order to suppress the bacteria.

07:40 EDT Southwestern Energy, Uniper execute supply agreement for RSG - Southwestern Energy announced a multi-year, certified Responsibly Sourced Gas RSG sales agreement to the North American subsidiary of Uniper, one of Germany's largest publicly listed energy supply companies. As part of the agreement, SWN will supply Uniper with RSG for its U.S. midstream gas portfolio that includes domestic distribution to downstream customers as well as natural gas to supply U.S. facilities for liquefaction and export to global LNG markets. RSG is a distinct natural gas classification that is verified for low-emission attributes and environmentally responsible production. The agreement represents the first RSG transaction for Uniper in the United States and its second in North America. "Transparency in energy production practices is a growing market interest, and agreements like this one are key to deploying responsibly sourced solutions for customers in the U.S. and abroad," said Marc Merrill, President and CEO for Uniper in North America. "Southwestern Energy's reputation as a first-mover in RSG makes it a valued supplier in assisting our customers achieve their critical supply objectives in a responsible manner."

07:38 EDT SimpleNexus announces Family First Funding has implemented Nexus Engagement - SimpleNexus, an nCino company, announced that independent mortgage bank Family First Funding has implemented Nexus Engagement, Nexus Origination and Nexus Closing to provide borrowers with a streamlined, single sign-on homebuying experience. Nexus Engagement helps lenders facilitate productive referral relationships and convert pre-application leads with features like integrated home search, a payment calculator and instant chat. "Developing a platform that helps lenders thrive and simplifies the home financing process for borrowers is incredibly rewarding," said SimpleNexus Founder Matt Hansen. "We are committed to continually enhancing our platform so that our customers can set the bar in their communities for what the homebuying experience should be."

07:36 EDT Statera appoints BF Borges as independent registered public accounting firm - Statera Biopharma announced the appointment of Certified Public Accountants, BF Borgers CPA PC as the Company's independent accountant to audit the balance sheet of the Company as of December 31, 2021, and the related statements of operations, stockholders' equity and income, and cash flows for the period ended December 31, 2021.

07:35 EDT Lilium chooses Expliseat to design, build the seats for its jet - Lilium has chosen French manufacturer Expliseat to design and build the pilot and passenger seats for the Lilium Jet. Expliseat specializes in lightweight and durable seating for aviation and other low carbon mobilities. The company has unique expertise in advanced materials such as carbon fiber and titanium, which makes their seats approximately 35% lighter than aviation seats typically made of aluminium. Lower seat mass contributes to a more efficient and sustainable aviation.

07:33 EDT Camping World buys Anthem RV in New River, AZ, no terms - Camping World Holdings announced an agreement to acquire the operating dealership Anthem RV located in New River, AZ, as well as a new site to be built in Surprise, AZ, both of which will serve the greater Phoenix area. The acquisition of the operating dealership in New River, AZ is anticipated to close next month and will add to Camping World's existing locations in Avondale, Mesa, and Tucson. "This acquisition is further acceleration of our growth strategy in 2022, by providing additional service and product excellence to our growing customer base in the Southwest," said Marcus Lemonis, CEO and Chairman of Camping World. "For over 10 years, Anthem RV has been highly respected in Arizona, with a strong culture of serving customers top selection and service. We look at this acquisition as a unique opportunity to rapidly increase our presence in this top RV sales market."

07:33 EDT Latham Group CFO Borseth to retire, Masson to succeed - Latham Group announced Mark Borseth's plans to retire from his position as Chief Financial Officer of the Company. Robert Masson has been named Latham's next Chief Financial Officer and will assume the responsibilities on July 11, 2022. Masson will report to Scott Rajeski, Latham President and Chief Executive Officer. Borseth will remain with Latham as a strategic advisor to the Company through December 31, 2022. Masson joins Latham from Hypertherm, Inc., a U.S. based manufacturer of cutting systems and software. He currently serves as Executive Vice President and Chief Financial Officer. .

07:30 EDT U.S. Steel appoints Jessica Graziano as CFO - United States Steel (X) announced the appointment of Jessica Graziano as senior VP and CFO, effective August 8. Graziano will report directly to David Burritt, president and CEO, and have responsibility for all aspects of finance, including financial planning and analysis, corporate accounting, tax, treasury, pension investments and investor relations. Before joining U. S. Steel, Ms. Graziano spent eight years with United Rentals (URI).

07:21 EDT Aerojet Rocketdyne Executive Chairman Lichtenstein sends letter to shareholders - Aerojet Rocketdyne Holdings Executive Chairman Warren Lichtenstein, who collectively with his affiliates and the participants in his solicitation owns approximately 5.6% of the Company's outstanding shares sent the below letter to shareholders in connection with a special meeting of shareholders scheduled to be held on June 30. "Thank you for your investment in Aerojet Rocketdyne and your willingness to evaluate the refreshed slate of director candidates I have nominated for election at the June 30th Special Meeting. "I want you to know it remains my privilege to be aligned with you and champion your interests in the boardroom. Since making an initial investment in 2000 and joining the Board in 2008, I have focused on helping the Company transform into a technology-led aerospace and defense business that can grow with its customers and produce long-term value for its shareholders. I am proud that this focus has helped drive an approximately 7x increase in the Company's market capitalization and more than 250% total shareholder returns. With that said, Aerojet Rocketdyne has to continue building on - not giving back or resting on - past results. I also want to acknowledge at this time that it has been a very difficult and tumultuous period for the Company. When Lockheed Martin terminated its acquisition in February following more than a year of very public headwinds, we were not prepared with the comprehensive contingency plan sought by myself and a subset of the Board - resulting in disruptions for employees, customers and shareholders. When it came time for the current Board to nominate a slate for the 2022 Annual Meeting, we were unable to reach consensus - resulting in more disruptions. Additionally, my differences of opinion with Chief Executive Officer Eileen Drake led her to initiate a distracting internal investigation and then compelled me to file litigation over her misuse of shareholders' resources to pursue boardroom control. Although I always seek to do what is in your best interest, I know the status quo is unacceptable and that all of the Company's stakeholders deserve better." In the lead-up to the Special Meeting, it has very much been a tale of two stories. Ms. Drake and her allies contend everything has been fine at Aerojet Rocketdyne except for me. They have consistently deflected attention away from the operational and financial deterioration that has set in over the last 18 months by attacking me - an engaged Executive Chairman who has put his money where his mouth is with a more than $150M stake and an irrefutable record of long-term value creation. They have maintained this posture even while Ms. Drake, who has never purchased a share of Aerojet Rocketdyne on the open market, has reportedly sought $48M of shareholders' money to leave. But rather than continue engaging in a tit-for-tat, I want to focus your attention on what actually matters today: since December 2020, a lack of contingency planning and poor operational oversight at Aerojet Rocketdyne has led to a nearly 80% decline in real free cash flow, numerous customer complaints, sustained employee attrition and several defense and space programs going from the black into the red. I would have fought harder from the boardroom to fix these issues had I not been effectively sidelined for most of the past 18 months by Ms. Drake's investigation and her management team's documented efforts to block my access. The fact that Ms. Drake's faction will not assume any accountability for these issues speaks volumes about its lack of credibility and unfitness to lead. By voting on the GREEN Proxy Card to elect my refreshed slate of director candidates at the upcoming Special Meeting, I am confident you can help usher in the better future we all want.

07:18 EDT Electrovaya appoints John Gibson as CFO - Electrovaya announces the appointment of John Gibson, as the CFO of Electrovaya effective as of June 13th, 2022. Mr. Gibson will report to Electrovaya's CEO, Dr. Raj DasGupta. Previously he served as VP Finance at Adlib Software and has held leadership roles in manufacturing for the last 10 years.

07:14 EDT Locafy acquires client base of 180 Degree Marketing - Locafy has acquired the client base of Australian digital agency 180 Degree Marketing as it ramps up its acquisition and partnership strategy. Based in Canberra, Australia 180 Degree services a number of national brands in the real estate, FMCG and finance sectors. Locafy's goal is to revolutionize the $700 billion search engine optimization market globally through seamlessly deploying to local businesses its patented search technology. Locafy will initially focus that strategy on key Australian and US markets.

07:13 EDT Clearside Biomedical appoints Coultas as Chief Clinical Officer - Clearside Biomedical (CLSD) announced the appointment of Susan Coultas, Ph.D., as Chief Clinical Officer. In this role, Dr. Coultas serves as a member of the executive team and has overall responsibility for planning the initiation and execution of Clearside's clinical trials, including oversight of all clinical development operations.. Most recently, Coultas served as Senior Vice President of Clinical Development at Kala Pharmaceuticals (KALA).

07:11 EDT Nuwellis expands pediatric access to Aquadex SmartFlow in Florida, Arkansas - Nuwellis announced its Aquadex SmartFlow system is now available at two new pediatric hospitals in Florida and Arkansas. "By expanding access to Aquadex, we are another step closer to fulfilling our purpose-driven mission of positively transforming the lives of people suffering from fluid overload," said Nestor Jaramillo, Jr., President and CEO of Nuwellis. "Fluid overload can quickly lead to severe complications, and children have limited treatment options. Our current technology gives providers a tool they can rely on to remove excess fluid effectively and efficiently. This commitment to pediatric patients has resulted in significant growth for this segment of our business."

07:09 EDT Ondas to join Russell 3000 Index - Ondas is set to join the broad-market Russell 3000 Index at the conclusion of the 2022 Russell indexes annual reconstitution, effective after the U.S. market opens on June 27, according to a preliminary list of additions posted June 10.

07:07 EDT EQRx announces acceptance of MAA by the UK's MHRA for aumolertinib - EQRx announced that the United Kingdom's, UK, Medicines and Healthcare products Regulatory Agency, MHRA, has accepted for review the marketing authorization application, MAA, for aumolertinib, a third-generation EGFR-tyrosine kinase inhibitor, TKI, in development for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer, NSCLC, with activating EGFR mutations and for the treatment of adult patients with locally advanced or metastatic EGFR T790M mutation-positive NSCLC. "This acceptance of the marketing authorization application for aumolertinib by the MHRA is our first regulatory filing and a significant milestone for EQRx," said Melanie Nallicheri, president and chief executive officer of EQRx. "In the U.K., approximately 39,000 people are diagnosed with lung cancer each year, and about 10 to 15 percent of these patients have EGFR-sensitizing mutations. Given its promising clinical activity and tolerability profile, we believe that, if approved, aumolertinib would represent an additional and differentiated treatment option for patients in the U.K. who have EGFR-mutated NSCLC. We aim to expand access to third generation EGFR inhibitors and look forward to working with the MHRA as it conducts its review."

07:05 EDT VersaBank subsidiary to acquire Stearns Bank Holdingford for $13.5M - VersaBank announced that, through its wholly owned U.S. subsidiary, VersaHoldings US, it has signed a definitive agreement to acquire Minnesota-based Stearns Bank Holdingford, a privately held, wholly owned subsidiary of Stearns Financial Services based in St. Cloud, Minnesota, for an estimated $13.5M, subject to adjustment at closing. SBH is a fully operational national bank, OCC-chartered Bank, focused on small business lending, which is expected to add approximately $60M in total assets to VersaBank, subject to any adjustments at closing. Upon closing, SBH will be renamed VersaBank USA National Association. SFSI and its other subsidiaries: Stearns Bank with $2.2B sets, and Stearns Bank Upsala, with $75M in assets, will continue to operate as usual. This deal provides VersaBank with access to U.S. deposits to fuel the growth of its Receivable Purchase Program business, which VersaBank recently launched in the U.S. following a period of significant growth and success in Canada. Transaction is expected to be accretive to VersaBank's EPS within the first year after closing; and VersaBank USA is expected to be well capitalized on closing with a Total Capital ratio in excess of 10%. Closing of the acquisition, expected before the end of VersaBank's fiscal year in October 31, is subject to regulatory approval in both the U.S. and Canada. Raymond James & Associates served as financial advisor, Davis Polk & Wardwell served as legal counsel, and Chain Bridge Partners, acted as regulatory advisor to VersaBank in the transaction.

07:04 EDT Yext announces partnership with what3words - Yext announced a partnership with what3words, a platform that's revolutionizing the way we communicate location. Through this partnership, businesses can more easily direct their customers to any precise location using a unique combination of three random words: a what3words address. For example, the exact 10ft tile representing the front door of the Yext NYC headquarters is ///lance.member.pines, whereas ///usual.trying.highs will take you to a spot that offers the best view of the Golden Gate Bridge in San Francisco. Yext customers who install the what3words app will automatically add what3words addresses to each of their location entities and can sync this new information across the Yext Publisher Network.

07:04 EDT EnLink Midstream CEO Barry Davis retires, Jesse Arenivas to succeed - EnLink Midstream (ENLC) announced that Chairman and CEO Barry Davis will retire from EnLink, the company he led the founding of, after more than 25 years of leadership. Davis will step down from his position as Chairman and CEO on June 20, at which point Jesse Arenivas will join EnLink as CEO and a director on the EnLink Board of Directors, and Leldon Echols will become the Chairman of the Board. Davis will continue in an advisory role until August 31, to ensure a seamless transition. Arenivas comes to EnLink after almost 20 years with Kinder Morgan (KMI), where he helped the company grow to become the largest transporter of CO2 in North America.

07:02 EDT Freeline imitates dosing of second cohort in B-LIEVE dose confirmation trial - Freeline Therapeutics announced that it has begun dosing the second cohort in its Phase 1/2 B-LIEVE dose confirmation trial of FLT180a in people with hemophilia B. Dosing of the first cohort was completed in April and initial data from that cohort will be presented at the International Society on Thrombosis and Haemostasis, ISTH, Congress being held July 9-13, 2022 in London, UK. "Our goal is to provide transformative and durable one-time treatments to people with severe chronic diseases. We are working with urgency to advance our therapeutic candidates and are focused on finding the most effective way of bringing them to patients," said Michael Parini, Chief Executive Officer of Freeline. "FLT180a is on track to deliver proof of concept that our gene therapies have the potential to achieve our goal. We continue to believe that executing in the clinic together with financial discipline and operational excellence will demonstrate Freeline's value for patients, potential partners and investors alike." Freeline plans to report updated B-LIEVE data in the second half of 2022 and the first half of 2023, and initiate Phase 3 start-up activities in the first half of 2023.

07:01 EDT CAE partners with Behaviour Interactive - CAE announced a partnership with Behaviour Interactive, an independent game developer. Under this agreement, these two Canadian companies, which are leaders in their respective fields of expertise, will combine their technological know-how to create innovative technological solutions. In addition, Behaviour Interactive will give CAE exclusive access to key multidisciplinary teams related to video game technology development. This partnership will enable CAE to integrate video game technology into its high-performance products, allowing it to develop immersive training technologies that are more revolutionary than ever before.

06:54 EDT Continental Resources announces receipt of $70.00 per share take private offer - Continental Resources announced that its board of directors has received a non-binding proposal letter, dated June 13 from Harold Hamm, on behalf of himself, the Harold G. Hamm Trust and certain trusts established for the benefit of Hamm's family members to acquire for cash all of the outstanding shares of common stock of Continental, other than shares of common stock owned by the Hamm Family and shares of common stock underlying unvested equity awards issued pursuant to Continental's long-term incentive plans. The Hamm Family's proposal of $70.00 per share represents an approximate 9% premium over Continental's closing price on June 13, a premium of approximately 11% to its volume weighted average price during the last 30 trading days through June 13, 2022 and a 21% premium to the volume weighted average price of the common stock traded during 2022. The Hamm Family collectively holds approximately 83% of the total outstanding shares of common stock. The board intends to establish a special committee consisting of independent directors of the board to consider the proposal. The board expects that the special committee will retain independent advisors, including independent financial and legal advisors, to assist it in this process. The proposal constitutes only an indication of interest by the Hamm Family and does not constitute a binding commitment with respect to the proposed transaction or any other transaction.

06:48 EDT Entain announces agreement to acquire BetCity - Entain plc announces that it has agreed to acquire the entire share capital of BetEnt B.V., which trades under the BetCity.nl name, from Sports Entertainment Media B.V. for an initial consideration of EUR 300M, or approximately GBP 257M, and deferred contingent consideration of up to EUR 550M, or approximately GBP 472M. Headquartered in Amsterdam, BetCity received an online sports betting and gaming license from the KSA, the Dutch Gaming and Gambling Authority, in October 2021 and is one of the Netherlands' leading online sports betting and gaming operators, Entain stated. "BetCity's offering is highly complementary to Entain's bwin and Party brands which are awaiting approval for a licence to operate in the Netherlands - now expected during the latter part of this year as the KSA has recently requested additional documentation as part of the ongoing application process. The combination of BetCity's local expertise, strong brand and large diverse user-base, with Entain's global scale and market-leading platform will provide customers with a broader offering of engaging products, fresh content and new experiences. Melvin Bostelaar, BetCity's CEO, along with other key members of the leadership team, will remain with the company," Entain stated. Reference Link

06:35 EDT InfuSystem and Ventis Pharma sign sales and marketing agreement - InfuSystem Holdings announced a national sales and marketing agreement with Ventis Pharma, a leader in advancing surgical and chronic pain management solutions. The partnership will focus on sales and marketing of Ventis Pharma's patented Endura-Kit brand of Enduracaine, a local anesthetic compound. Endura-Kit consists of three non-opioid drugs - tetracaine, lidocaine and epinephrine.

05:30 EDT Eli Lilly, Incyte announce FDA approval of Olumiant - Eli Lilly (LLY) and Incyte (INCY) announced that the FDA has approved Olumiant, a once-daily pill, as a first-in-disease systemic treatment for adults with severe alopecia areata, or AA, available as 4-mg, 2-mg and 1-mg tablets. The recommended dose is Olumiant 2-mg/day, with an increase to 4-mg/day if treatment response is inadequate. For patients with nearly complete or complete scalp hair loss, with or without substantial eyelash or eyebrow hair loss, consider treating with 4-mg/day. Once an adequate response is achieved on 4-mg/day, the dosage is to be decreased to 2-mg/day. Olumiant is not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, cyclosporine or other potent immunosuppressants.

05:22 EDT Vaalco Energy to join Russell 3000 Index - Vaalco Energy announced it is set to join the broad-market Russell 3000 Index at the conclusion of the 2022 Russell Indexes Annual Reconstitution, according to a preliminary list of additions posted by FTSE Russell on June 3. Inclusion in the index will take effect after the U.S. market opens on June 27.

05:19 EDT PureTech Health achieves proof-of-principle for Glyph platform in LYT-300 study - PureTech Health announced the achievement of proof-of-principle for its Glyph platform in a healthy adult study of LYT-300, PureTech's wholly-owned therapeutic candidate for the potential treatment of a range of neurological and neuropsychological conditions. This is a key milestone for the candidate, which is designed to overcome the normally poor oral bioavailability of allopregnanolone to deliver its proven efficacy via simple, convenient oral dosing. This is also the first mechanistic proof-of-principle in the clinic for PureTech's Glyph lymphatic targeting platform, which is designed to bypass first-pass metabolism to help maximize the therapeutic potential of validated targets and drugs where oral bioavailability has been a barrier. The Glyph platform is also designed to have additional applications through its ability to selectively traffic therapeutics into the lymphatic system, potentially enabling more direct targeting of the immune system.

05:12 EDT Dr. Reddy's launches generic equivalent of Nexavar Tablets in U.S - Dr. Reddy's announced the launch of Dr. Reddy's Sorafenib Tablets, USP, 200 mg, a therapeutic generic equivalent of Nexavar Tablets in the U.S. market following the approval by the FDA.

05:05 EDT Sunlands Online announces $1.36 per share special cash dividend - Sunlands Technology Group announced that the board of directors of the company has declared a special cash dividend of $1.36 per ordinary share, or 68c per American Depositary Share, or ADS, to holders of the company's ordinary shares and ADSs of record at the close of business on June 30, Beijing/Hong Kong Time and New York Time, respectively, payable in U.S. dollars. Dividends to such holders are expected to be distributed on or about July 29.